| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.917 | 0.003 | 0.917 | Antihistaminic | 0.666 0.004 DBMET00752 0.666 0.004 DBMET00761 | ||
| 0.914 | 0.003 | 0.914 | Histamine antagonist | 0.645 0.004 DBMET00752 0.645 0.004 DBMET00761 | ||
| 0.912 | 0.002 | 0.912 | Histamine H1 receptor antagonist | 0.76 0.003 DBMET00752 0.76 0.003 DBMET00761 | ||
| 0.493 | 0.002 | 0.493 | 5 Hydroxytryptamine 3 agonist | 0.402 0.002 DBMET00752 0.402 0.002 DBMET00761 | ||
| 0.436 | 0.01 | 0.436 | 5 Hydroxytryptamine antagonist | 0.25 0.025 DBMET00752 0.25 0.025 DBMET00761 | ||
| 0.435 | 0.012 | 0.437 | Cyclic AMP phosphodiesterase inhibitor | 0.437 0.012 DBMET00752 0.437 0.012 DBMET00761 | DBMET00761 | |
| 0.417 | 0.005 | 0.417 | Acetylcholine M1 receptor antagonist | 0.39 0.006 DBMET00752 0.39 0.006 DBMET00761 | ||
| 0.44 | 0.033 | 0.461 | Spasmolytic | 0.461 0.029 DBMET00752 0.461 0.029 DBMET00761 | DBMET00761 | |
| 0.401 | 0.003 | 0.401 | 5 Hydroxytryptamine 3 antagonist | 0.167 0.008 DBMET00752 0.167 0.008 DBMET00761 | ||
| 0.432 | 0.046 | 0.432 | Vasodilator, peripheral | 0.411 0.052 DBMET00752 0.411 0.052 DBMET00761 | ||
| 0.443 | 0.07 | 0.444 | Cyclophilin D inhibitor | 0.444 0.069 DBMET00752 0.444 0.069 DBMET00761 | DBMET00761 | |
| 0.397 | 0.028 | 0.397 | HERG channel blocker | 0.213 0.083 DBMET00752 0.213 0.083 DBMET00761 | ||
| 0.391 | 0.024 | 0.391 | Potassium channel blocker | 0.217 0.082 DBMET00752 0.217 0.082 DBMET00761 | ||
| 0.373 | 0.011 | 0.373 | 5 Hydroxytryptamine 2 antagonist | 0.244 0.022 DBMET00752 0.244 0.022 DBMET00761 | ||
| 0.397 | 0.036 | 0.397 | Vasodilator, coronary | 0.394 0.037 DBMET00752 0.394 0.037 DBMET00761 | ||
| 0.364 | 0.049 | 0.364 | Nootropic | 0.257 0.102 DBMET00752 0.257 0.102 DBMET00761 | ||
| 0.317 | 0.01 | 0.317 | 5 Hydroxytryptamine 2A antagonist | 0.193 0.02 DBMET00752 0.193 0.02 DBMET00761 | ||
| 0.3 | 0.003 | 0.3 | 5 Hydroxytryptamine 3B antagonist | 0.111 0.004 DBMET00752 0.111 0.004 DBMET00761 | ||
| 0.328 | 0.041 | 0.328 | Potassium channel (Voltage-sensitive) blocker | 0.178 0.114 DBMET00752 0.178 0.114 DBMET00761 | ||
| 0.292 | 0.014 | 0.292 | Toll-Like receptor 9 antagonist | 0.257 0.019 DBMET00752 0.257 0.019 DBMET00761 | ||
| 0.273 | 0.019 | 0.273 | Antipruritic | 0.255 0.023 DBMET00752 0.255 0.023 DBMET00761 | ||
| 0.309 | 0.062 | 0.384 | Hypoxia-inducible factor 1 alpha inhibitor | 0.384 0.034 DBMET00752 0.384 0.034 DBMET00761 | DBMET00761 | |
| 0.243 | 0.003 | 0.243 | 5 Hydroxytryptamine 3A antagonist | 0.121 0.009 DBMET00752 0.121 0.009 DBMET00761 | ||
| 0.316 | 0.077 | 0.316 | Calcium channel activator | 0.311 0.081 DBMET00752 0.311 0.081 DBMET00761 | ||
| 0.239 | 0.005 | 0.239 | Phosphodiesterase 5A inhibitor | 0.191 0.006 DBMET00752 0.191 0.006 DBMET00761 | ||
| 0.252 | 0.019 | 0.252 | Glycogen synthase kinase-3 beta inhibitor | 0.177 0.034 DBMET00752 0.177 0.034 DBMET00761 | ||
| 0.236 | 0.005 | 0.236 | Phosphodiesterase V inhibitor | 0.186 0.007 DBMET00752 0.186 0.007 DBMET00761 | ||
| 0.246 | 0.015 | 0.246 | Acetylcholine muscarinic antagonist | 0.215 0.021 DBMET00752 0.215 0.021 DBMET00761 | ||
| 0.248 | 0.02 | 0.248 | Alpha adrenoreceptor antagonist | 0.221 0.024 DBMET00752 0.221 0.024 DBMET00761 | ||
| 0.242 | 0.023 | 0.242 | Cholinergic antagonist | 0.209 0.029 DBMET00752 0.209 0.029 DBMET00761 | ||
| 0.243 | 0.023 | 0.243 | Glycogen synthase kinase-3 inhibitor | 0.164 0.041 DBMET00752 0.164 0.041 DBMET00761 | ||
| 0.233 | 0.023 | 0.233 | Acetylcholine antagonist | 0.201 0.03 DBMET00752 0.201 0.03 DBMET00761 | ||
| 0.198 | 0.013 | 0.198 | 5 Hydroxytryptamine 7 antagonist | 0.111 0.023 DBMET00752 0.111 0.023 DBMET00761 | ||
| 0.196 | 0.019 | 0.196 | Alpha 2c adrenoreceptor antagonist | 0.174 0.024 DBMET00752 0.174 0.024 DBMET00761 | ||
| 0.248 | 0.08 | 0.248 | Interleukin agonist | 0.209 0.112 DBMET00752 0.209 0.112 DBMET00761 | ||
| 0.188 | 0.027 | 0.188 | Alpha 2b adrenoreceptor antagonist | 0.162 0.034 DBMET00752 0.162 0.034 DBMET00761 | ||
| 0.217 | 0.056 | 0.224 | Sigma receptor agonist | 0.224 0.055 DBMET00752 0.224 0.055 DBMET00761 | DBMET00761 | |
| 0.201 | 0.041 | 0.215 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.215 0.038 DBMET00752 0.215 0.038 DBMET00761 | DBMET00761 | |
| 0.187 | 0.027 | 0.187 | Antiadrenergic | 0.172 0.03 DBMET00752 0.172 0.03 DBMET00761 | ||
| 0.183 | 0.027 | 0.183 | Adrenaline antagonist | 0.168 0.03 DBMET00752 0.168 0.03 DBMET00761 | ||
| 0.172 | 0.02 | 0.172 | Acetylcholine agonist | 0.084 0.061 DBMET00752 0.084 0.061 DBMET00761 | ||
| 0.161 | 0.014 | 0.161 | Acetylcholine M3 receptor agonist | 0.133 0.028 DBMET00752 0.133 0.028 DBMET00761 | ||
| 0.191 | 0.045 | 0.191 | MAP kinase kinase 5 inhibitor | 0.187 0.049 DBMET00752 0.187 0.049 DBMET00761 | ||
| 0.325 | 0.18 | 0.325 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.154 | 0.01 | 0.154 | Acetylcholine muscarinic agonist | 0.048 0.046 DBMET00752 0.048 0.046 DBMET00761 | ||
| 0.148 | 0.005 | 0.148 | Acetylcholine M5 receptor agonist | 0.108 0.016 DBMET00752 0.108 0.016 DBMET00761 | ||
| 0.156 | 0.019 | 0.156 | Phosphodiesterase 7B inhibitor | 0.118 0.039 DBMET00752 0.118 0.039 DBMET00761 | ||
| 0.153 | 0.029 | 0.153 | Alpha 1 adrenoreceptor antagonist | 0.127 0.035 DBMET00752 0.127 0.035 DBMET00761 | ||
| 0.145 | 0.021 | 0.145 | 5 Hydroxytryptamine 1A antagonist | 0.098 0.033 DBMET00752 0.098 0.033 DBMET00761 | ||
| 0.204 | 0.08 | 0.204 | Anticonvulsant | |||
| 0.155 | 0.033 | 0.155 | Polo-like kinase-4 inhibitor | 0.134 0.046 DBMET00752 0.134 0.046 DBMET00761 | ||
| 0.224 | 0.103 | 0.224 | 5 Hydroxytryptamine release stimulant | 0.192 0.129 DBMET00752 0.192 0.129 DBMET00761 | ||
| 0.193 | 0.074 | 0.193 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.165 | 0.048 | 0.165 | Calcium channel blocker | |||
| 0.297 | 0.184 | 0.297 | MAP kinase 1 inhibitor | 0.282 0.2 DBMET00752 0.282 0.2 DBMET00761 | ||
| 0.114 | 0.005 | 0.114 | 5 Hydroxytryptamine 4 antagonist | 0.088 0.01 DBMET00752 0.088 0.01 DBMET00761 | ||
| 0.135 | 0.026 | 0.135 | 5 Hydroxytryptamine 1 antagonist | 0.083 0.045 DBMET00752 0.083 0.045 DBMET00761 | ||
| 0.122 | 0.014 | 0.122 | Caspase 7 inhibitor | 0.095 0.034 DBMET00752 0.095 0.034 DBMET00761 | ||
| 0.136 | 0.028 | 0.136 | Dopamine antagonist | 0.119 0.032 DBMET00752 0.119 0.032 DBMET00761 | ||
| 0.137 | 0.031 | 0.137 | Alpha 2 adrenoreceptor antagonist | 0.115 0.039 DBMET00752 0.115 0.039 DBMET00761 | ||
| 0.109 | 0.004 | 0.109 | Acetylcholine M4 receptor agonist | 0.037 0.016 DBMET00752 0.037 0.016 DBMET00761 | ||
| 0.13 | 0.025 | 0.13 | Dopamine D2 antagonist | 0.117 0.028 DBMET00752 0.117 0.028 DBMET00761 | ||
| 0.254 | 0.15 | 0.313 | GABA C receptor rho-3 antagonist | 0.313 0.108 DBMET00752 0.313 0.108 DBMET00761 | DBMET00761 | |
| 0.13 | 0.027 | 0.13 | Alpha 2a adrenoreceptor antagonist | 0.121 0.029 DBMET00752 0.121 0.029 DBMET00761 | ||
| 0.124 | 0.021 | 0.126 | Phosphodiesterase 6D inhibitor | 0.126 0.02 DBMET00752 0.126 0.02 DBMET00761 | DBMET00761 | |
| 0.122 | 0.02 | 0.122 | Histamine H2 receptor antagonist | 0.088 0.05 DBMET00752 0.088 0.05 DBMET00761 | ||
| 0.112 | 0.01 | 0.112 | Histamine H3 receptor antagonist | |||
| 0.115 | 0.013 | 0.116 | Phosphodiesterase VI inhibitor | 0.116 0.013 DBMET00752 0.116 0.013 DBMET00761 | DBMET00761 | |
| 0.13 | 0.036 | 0.13 | Gastric antisecretory | 0.116 0.047 DBMET00752 0.116 0.047 DBMET00761 | ||
| 0.114 | 0.02 | 0.114 | Acetylcholine M4 receptor antagonist | 0.066 0.062 DBMET00752 0.066 0.062 DBMET00761 | ||
| 0.141 | 0.048 | 0.141 | Beta amyloid protein antagonist | 0.124 0.063 DBMET00752 0.124 0.063 DBMET00761 | ||
| 0.096 | 0.005 | 0.096 | Alpha 1L adrenoreceptor antagonist | 0.094 0.005 DBMET00752 0.094 0.005 DBMET00761 | ||
| 0.132 | 0.041 | 0.132 | Transcription factor STAT6 inhibitor | 0.127 0.049 DBMET00752 0.127 0.049 DBMET00761 | ||
| 0.197 | 0.106 | 0.324 | Aldehyde oxidase inhibitor | 0.324 0.06 DBMET00752 0.324 0.06 DBMET00761 | DBMET00761 | |
| 0.148 | 0.057 | 0.148 | Toll-Like receptor antagonist | 0.146 0.058 DBMET00752 0.146 0.058 DBMET00761 | ||
| 0.148 | 0.06 | 0.148 | Phosphodiesterase inhibitor | 0.113 0.089 DBMET00752 0.113 0.089 DBMET00761 | ||
| 0.092 | 0.006 | 0.092 | Histamine H4 receptor antagonist | 0.049 0.033 DBMET00752 0.049 0.033 DBMET00761 | ||
| 0.133 | 0.049 | 0.133 | 5 Hydroxytryptamine 2B antagonist | 0.104 0.078 DBMET00752 0.104 0.078 DBMET00761 | ||
| 0.243 | 0.16 | 0.298 | Histamine release inhibitor | 0.298 0.124 DBMET00752 0.298 0.124 DBMET00761 | DBMET00761 | |
| 0.13 | 0.048 | 0.13 | GABA receptor agonist | |||
| 0.212 | 0.131 | 0.212 | Gastrin inhibitor | |||
| 0.092 | 0.012 | 0.092 | Phosphodiesterase 1A inhibitor | 0.061 0.039 DBMET00752 0.061 0.039 DBMET00761 | ||
| 0.179 | 0.098 | 0.195 | Platelet aggregation inhibitor | 0.195 0.085 DBMET00752 0.195 0.085 DBMET00761 | DBMET00761 | |
| 0.111 | 0.032 | 0.111 | Alpha 1a adrenoreceptor antagonist | 0.089 0.041 DBMET00752 0.089 0.041 DBMET00761 | ||
| 0.172 | 0.098 | 0.172 | Psychostimulant | 0.165 0.104 DBMET00752 0.165 0.104 DBMET00761 | ||
| 0.086 | 0.017 | 0.086 | Cyclin-dependent kinase 6 inhibitor | 0.061 0.04 DBMET00752 0.061 0.04 DBMET00761 | ||
| 0.11 | 0.041 | 0.11 | Calcium antagonist | |||
| 0.114 | 0.046 | 0.114 | Insulin receptor antagonist | 0.091 0.076 DBMET00752 0.091 0.076 DBMET00761 | ||
| 0.091 | 0.024 | 0.091 | Acetylcholine M2 receptor antagonist | 0.07 0.037 DBMET00752 0.07 0.037 DBMET00761 | ||
| 0.219 | 0.155 | 0.219 | Antithrombotic | 0.206 0.17 DBMET00752 0.206 0.17 DBMET00761 | ||
| 0.164 | 0.1 | 0.164 | Anesthetic general | 0.149 0.115 DBMET00752 0.149 0.115 DBMET00761 | ||
| 0.08 | 0.016 | 0.08 | Acetylcholine M1 receptor agonist | |||
| 0.074 | 0.015 | 0.074 | Potassium channel (Inward rectifier) blocker | |||
| 0.086 | 0.028 | 0.086 | MAP kinase 7 inhibitor | 0.083 0.033 DBMET00752 0.083 0.033 DBMET00761 | ||
| 0.077 | 0.02 | 0.077 | Potassium channel (Ca-activated) blocker | 0.06 0.042 DBMET00752 0.06 0.042 DBMET00761 | ||
| 0.1 | 0.043 | 0.1 | Glutamate release inhibitor | 0.093 0.055 DBMET00752 0.093 0.055 DBMET00761 | ||
| 0.1 | 0.044 | 0.1 | Phosphodiesterase I inhibitor | 0.087 0.063 DBMET00752 0.087 0.063 DBMET00761 | ||
| 0.073 | 0.017 | 0.073 | Histamine agonist | |||
| 0.085 | 0.03 | 0.133 | Dopamine D1 antagonist | 0.133 0.017 DBMET00752 0.133 0.017 DBMET00761 | DBMET00761 | |
| 0.092 | 0.039 | 0.092 | Alpha 1b adrenoreceptor antagonist | 0.08 0.046 DBMET00752 0.08 0.046 DBMET00761 | ||
| 0.115 | 0.063 | 0.115 | Calcium channel (voltage-sensitive) blocker | |||
| 0.061 | 0.012 | 0.061 | Cytokine production stimulant | 0.051 0.026 DBMET00752 0.051 0.026 DBMET00761 | ||
| 0.064 | 0.015 | 0.064 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.1 | 0.051 | 0.1 | Toll-Like receptor 3 antagonist | |||
| 0.135 | 0.087 | 0.135 | Cytidine deaminase inhibitor | |||
| 0.052 | 0.004 | 0.052 | Adenosine uptake inhibitor | 0.042 0.009 DBMET00752 0.042 0.009 DBMET00761 | ||
| 0.083 | 0.036 | 0.083 | Alpha adrenoreceptor agonist | 0.08 0.038 DBMET00752 0.08 0.038 DBMET00761 | ||
| 0.194 | 0.147 | 0.228 | Tyrosine 3 hydroxylase inhibitor | 0.228 0.093 DBMET00752 0.228 0.093 DBMET00761 | DBMET00761 | |
| 0.068 | 0.021 | 0.068 | Acetylcholine M2 receptor agonist | 0.054 0.037 DBMET00752 0.054 0.037 DBMET00761 | ||
| 0.18 | 0.134 | 0.234 | Hypoglycemic | 0.234 0.087 DBMET00752 0.234 0.087 DBMET00761 | DBMET00761 | |
| 0.073 | 0.029 | 0.073 | Acetylcholine M5 receptor antagonist | 0.054 0.053 DBMET00752 0.054 0.053 DBMET00761 | ||
| 0.086 | 0.044 | 0.086 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.1 | 0.058 | 0.1 | Interleukin 1 beta converting enzyme inhibitor | 0.09 0.071 DBMET00752 0.09 0.071 DBMET00761 | ||
| 0.069 | 0.029 | 0.069 | Alpha 1 adrenoreceptor agonist | 0.063 0.033 DBMET00752 0.063 0.033 DBMET00761 | ||
| 0.125 | 0.085 | 0.125 | Cytokine production inhibitor | |||
| 0.088 | 0.05 | 0.088 | GABA A receptor agonist | |||
| 0.088 | 0.051 | 0.088 | mTOR complex 2 inhibitor | |||
| 0.061 | 0.025 | 0.061 | Dipeptidyl peptidase inhibitor | |||
| 0.068 | 0.034 | 0.068 | Alpha 2 adrenoreceptor agonist | 0.055 0.05 DBMET00752 0.055 0.05 DBMET00761 | ||
| 0.084 | 0.051 | 0.084 | Phosphodiesterase 11A inhibitor | |||
| 0.084 | 0.051 | 0.084 | Phosphodiesterase XI inhibitor | |||
| 0.128 | 0.096 | 0.128 | Diuretic | |||
| 0.108 | 0.076 | 0.108 | Anesthetic local | |||
| 0.113 | 0.082 | 0.113 | Nav1.3 sodium channel blocker | |||
| 0.065 | 0.036 | 0.065 | Phosphodiesterase 1B inhibitor | |||
| 0.074 | 0.045 | 0.074 | 5 Hydroxytryptamine agonist | |||
| 0.085 | 0.057 | 0.085 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.033 | 0.005 | 0.033 | Phosphodiesterase 6A inhibitor | 0.028 0.008 DBMET00752 0.028 0.008 DBMET00761 | ||
| 0.102 | 0.074 | 0.102 | Multidrug resistance-associated protein 1 inhibitor | 0.099 0.081 DBMET00752 0.099 0.081 DBMET00761 | ||
| 0.049 | 0.023 | 0.049 | Dipeptidyl peptidase IV inhibitor | |||
| 0.051 | 0.025 | 0.054 | Dopamine D5 antagonist | 0.054 0.023 DBMET00752 0.054 0.023 DBMET00761 | DBMET00761 | |
| 0.067 | 0.042 | 0.067 | Adenosine A2 receptor antagonist | |||
| 0.066 | 0.041 | 0.066 | Interferon inducer | |||
| 0.063 | 0.039 | 0.063 | Alpha 1d adrenoreceptor antagonist | |||
| 0.034 | 0.013 | 0.034 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.077 | 0.057 | 0.077 | Interferon agonist | |||
| 0.118 | 0.098 | 0.118 | Activin receptor-like kinase 2 inhibitor | |||
| 0.216 | 0.196 | 0.306 | 15-Lipoxygenase inhibitor | 0.306 0.128 DBMET00752 0.306 0.128 DBMET00761 | DBMET00761 | |
| 0.051 | 0.032 | 0.051 | Adenosine A2b receptor antagonist | |||
| 0.062 | 0.044 | 0.062 | Phosphodiesterase 1C inhibitor | |||
| 0.046 | 0.028 | 0.054 | Phosphodiesterase 3B inhibitor | 0.054 0.022 DBMET00752 0.054 0.022 DBMET00761 | DBMET00761 | |
| 0.047 | 0.029 | 0.047 | Phosphodiesterase 6C inhibitor | 0.044 0.042 DBMET00752 0.044 0.042 DBMET00761 | ||
| 0.054 | 0.036 | 0.054 | 5 Hydroxytryptamine 1 agonist | |||
| 0.076 | 0.06 | 0.076 | Acetylcholine nicotinic antagonist | |||
| 0.096 | 0.081 | 0.096 | 5 Hydroxytryptamine 3A agonist | |||
| 0.019 | 0.004 | 0.019 | Cyclin D2 inhibitor | 0.013 0.011 DBMET00752 0.013 0.011 DBMET00761 | ||
| 0.056 | 0.042 | 0.056 | Dopamine uptake inhibitor | |||
| 0.046 | 0.032 | 0.046 | 5 Hydroxytryptamine 1A agonist | |||
| 0.059 | 0.046 | 0.059 | Adenosine A2a receptor antagonist | |||
| 0.04 | 0.027 | 0.04 | Cyclin D3 inhibitor | |||
| 0.033 | 0.021 | 0.033 | Vanilloid 4 antagonist | |||
| 0.065 | 0.054 | 0.065 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.056 | 0.047 | 0.057 | Gonadotropin-releasing hormone receptor agonist | 0.057 0.045 DBMET00752 0.057 0.045 DBMET00761 | DBMET00761 | |
| 0.044 | 0.037 | 0.044 | CC chemokine 4 receptor antagonist | |||
| 0.05 | 0.043 | 0.05 | 5 Hydroxytryptamine 1B agonist | |||
| 0.065 | 0.058 | 0.065 | Protein kinase C beta inhibitor | |||
| 0.03 | 0.022 | 0.03 | Phosphodiesterase 6B inhibitor | |||
| 0.129 | 0.123 | 0.129 | Ca2+-transporting ATPase inhibitor | |||
| 0.1 | 0.095 | 0.1 | Calcium channel N-type blocker | |||
| 0.035 | 0.031 | 0.035 | Delayed rectifier potassium channel blocker | |||
| 0.047 | 0.044 | 0.047 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.054 | 0.051 | 0.054 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.049 | 0.047 | 0.049 | Lysine-specific demethylase 1A inhibitor | |||
| 0.048 | 0.047 | 0.054 | Protein kinase C eta inhibitor | 0.054 0.039 DBMET00752 0.054 0.039 DBMET00761 | DBMET00761 | |
| 0.034 | 0.041 | 0.056 | Dopamine D2 agonist | 0.056 0.023 DBMET00752 0.056 0.023 DBMET00761 | DBMET00761 | |
| 0.147 | 0.162 | 0.171 | Vasodilator | 0.171 0.131 DBMET00752 0.171 0.131 DBMET00761 | DBMET00761 | |
| 0.126 | 0.143 | 0.129 | Heat shock protein 70 antagonist | 0.129 0.127 DBMET00752 0.129 0.127 DBMET00761 | DBMET00761 | |
| 0.077 | 0.095 | 0.092 | Protein kinase C zeta inhibitor | 0.092 0.062 DBMET00752 0.092 0.062 DBMET00761 | DBMET00761 | |
| 0.046 | 0.068 | 0.067 | Dopamine agonist | 0.067 0.046 DBMET00752 0.067 0.046 DBMET00761 | DBMET00761 | |
| 0.152 | 0.199 | 0.17 | DNA synthesis inhibitor | 0.17 0.168 DBMET00752 0.17 0.168 DBMET00761 | DBMET00761 | |
| 0.15 | 0.198 | 0.17 | RNA-directed DNA polymerase inhibitor | 0.17 0.153 DBMET00752 0.17 0.153 DBMET00761 | DBMET00761 | |
| 0.114 | 0.163 | 0.174 | DNA methylase inhibitor | 0.174 0.098 DBMET00752 0.174 0.098 DBMET00761 | DBMET00761 | |
| 0.042 | 0.098 | 0.064 | Heat shock protein 90 beta antagonist | 0.064 0.034 DBMET00752 0.064 0.034 DBMET00761 | DBMET00761 | |
| 0.019 | 0.106 | 0.033 | Estrogen-related receptor beta antagonist | 0.033 0.022 DBMET00752 0.033 0.022 DBMET00761 | DBMET00761 | |
| 0.113 | 0.228 | 0.143 | Neurotensin receptor agonist | 0.143 0.12 DBMET00752 0.143 0.12 DBMET00761 | DBMET00761 | |
| 0.13 | 0.253 | 0.17 | ErbB-1 antagonist | 0.17 0.133 DBMET00752 0.17 0.133 DBMET00761 | DBMET00761 | |
| 0.056 | 0.208 | 0.128 | Lipid peroxidase inhibitor | 0.128 0.086 DBMET00752 0.128 0.086 DBMET00761 | DBMET00761 | |
| 0.185 | 0.344 | 0.261 | Caspase 9 stimulant | 0.261 0.239 DBMET00752 0.261 0.239 DBMET00761 | DBMET00761 | |
| 0.044 | 0.217 | 0.07 | Estrogen receptor alpha antagonist | 0.07 0.068 DBMET00752 0.07 0.068 DBMET00761 | DBMET00761 | |
| 0.162 | 0.355 | 0.335 | Calcium channel L-type activator | 0.335 0.129 DBMET00752 0.335 0.129 DBMET00761 | DBMET00761 | |
| 0.042 | 0.257 | 0.116 | Estrogen receptor beta antagonist | 0.116 0.037 DBMET00752 0.116 0.037 DBMET00761 | DBMET00761 | |
| 0.05 | 0.284 | 0.126 | Estrogen antagonist | 0.126 0.045 DBMET00752 0.126 0.045 DBMET00761 | DBMET00761 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |